Biosimilars Targeting Pathogens: A Comprehensive Review of Their Role in Bacterial, Fungal, Parasitic, and Viral Infections by Mohamed Halawa, Ramez M. Rashad ElSayed, Tope Aderibigbe, Precious M. Newman, Briana E. Reid, Valerie J. Carabetta

Subjects: “…antibacterial biosimilars…”
Get full text

Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum by O. A. Eliseeva, M. A. Kolganova, I. E. Shokhin, S. P. Dementyev, A. M. Vlasov, A. A. Zamyatnin, N. S. Dubovik, A. Yu. Savchenko, N. V. Dozmorova, V. G. Luzhanin

Subjects: Get full text

Approaches to resolve practical challenges in the context of assessing the price of biosimilar products by A. H.-M. Valeeva, M. I. Baranova

Subjects: “…biosimilars…”
Get full text

Results of a retrospective study of the clinical efficacy and safety of insulin RinFast® in children with type 1 diabetes mellitus by O. A. Dianov, D. A. Oleynik, A. V. Fofanova

Subjects: Get full text

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy by Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

Subjects: Get full text

Options to optimize the access to biosimilars: analysis and solutions by O. V. Kirsanova, V. V. Omelyanovsky

Subjects: “…biosimilars…”
Get full text

Perception toward Biosimilars and Nonmedical Switching: A Cross-sectional Survey among Arab Rheumatologists by Mohammed A. Omair, Humaid Al Wahshi, Jamal Al Saleh, Farida Al Balushi, Mostafa Zayed, Maha A. Omair, Eduardo Mysler

Subjects: Get full text

BIOSIMILARS IN RHEUMATOLOGY by E. L. Nasonov

Subjects: Get full text

Evaluation of rheumatologists’ knowledge of biosimilars by Thayane Furtado Rolim Lima, Lia Poti Gomes Cordeiro, Kirla Wagner Poti Gomes, Carlos Ewerton Maia Rodrigues

Subjects: “…Biosimilars…”
Get full text

Biologics and biosimilars in axial spondyloarthritis: Lots of kids on the block! by Concepcion Castillo-Gallego, Xabier Michelena, Helena Marzo-Ortega

Subjects: Get full text

A Double-blind Randomized Comparative Phase I Study to Assess Biosimilarity and Immunogenicity of "Trastuzumab" (LLC "Mabscale", Russia) and Herceptin® (F. Hoffmann-La Roche Ltd.,... by M. A. Kolganova, E. E. Beketov, V. V. Pisarev, A. V. Ivanov, S. V. Vasiliev, I. E. Shokhin

Subjects: Get full text

Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers by Fernando Perez-Ruiz, Elena Garmendia-Sanchez, Javier Arostegui-Lavilla, Javier Duruelo-Echevarrieta, Joana Atxotegi-Saenz de Buruaga, Mayra Nathali Rivas-Zavaleta, Javier Casas-Arrate, Maria del Consuelo Modesto-Caballero, Amaya de Basagoiti-Gorordo

Subjects: Get full text

Research and pilot analysis of bevacizumab repurposing potential and its impact in clinical practice by Antonio Ivanov, Violeta Getova-Kolarova, Valentina Belcheva, Evgeni Grigorov, Ilko Getov

Subjects: Get full text

Spanish Society of Hospital Pharmacy position paper on biosimilar medicines by Noemí Martínez-López de Castro, María Belén Matilla-Fernández, María Dolores Fraga-Fuentes, Irene Mangues-Bafalluy, Rocío Asensi-Díez, Gerardo Cajaraville-Ordoñana

Subjects: “…Biosimilars…”
Get full text

Quantification of the cellular content of platelet-rich plasma harvested after injection of filgrastim versus pegfilgrastim biosimilars: a prospective, single-center, crossover stu... by Mohammadreza Abbasian, Eric Branch, Ali Parsa, Jessica Truett, Joshua J. Cook, Charlkesha A. Rahming, Adam W. Anz

Subjects: “…Biosimilars…”
Get full text

Bridging the gap: The future of biosimilars regulations by Anan S. Jarab, Shrouq R Abu Heshmeh, Ahmad Z. Al Meslamani

Subjects: “…Biosimilars…”
Get full text

Biologics in ocular inflammatory diseases – Experience from a tertiary referral eye care center in South India by Kalpana Babu, PG Padmapriya, Anand P Rao, Ramesh Jois

Subjects: Get full text

Comparison of the efficacy and safety of the original rituximab and its biosimilar in routine clinical practice by D. A. Kusevich, Yu. A. Olyunin, E. L. Nasonov

Subjects: Get full text

Biosynthesis and Characterization of Vosoritide by <i>Escherichia coli</i> by Shuaiyi Huang, Xiaoyue Hu, Tao Luo, Jun Xu, Yu Duan, Jianguang Lu, Jun Feng

Subjects: Get full text

Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia by A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova

Subjects: Get full text